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Abstract
Background: Stromal derived factor (SDF-1), an alpha chemokine, is a widely known
chemoattractant in the immune system. A growing body of evidence now suggests multiple
regulatory roles for SDF-1 in the developing nervous system.
Results: To investigate the role of SDF-1 signaling in the growth and differentiation of cortical cells,
we performed numerous in vitro experiments, including gene chip and quantitative RT-PCR analysis.
Using SDF-1 medium and AMD3100, a receptor antagonist, we demonstrate that the chemokine
signaling regulates key events during early cortical development. First, SDF-1 signaling maintains
cortical progenitors in proliferation, possibly through a mechanism involving connexin 43 mediated
intercellular coupling. Second, SDF-1 signaling upregulates the differentiation of cortical GABAergic
neurons, independent of sonic signaling pathway. Third, SDF-1 enables the elongation and
branching of axons of cortical glutamatergic neurons. Finally, cortical cultures derived from
CXCR4-/- mutants show a close parallel to AMD3100 treatment with reduced cell proliferation
and differentiation of GABAergic neurons.
Conclusion: Results from this study show that SDF-1 regulates distinct cortical cell populations
in vitro.
Background
The cerebral cortex is primarily composed of glutamater-
gic pyramidal neurons of dorsal telencephalon and
GABAergic interneurons that emanate from ventral telen-
cephalon [1]. The generation of cortical neurons is a
tightly orchestrated process that involves the commitment
of multipotent stem cells to lineage-restricted progenitors,
progression of progenitors to postmitotic neurons and
their subsequent migration to correct layer positions. The
molecular mechanisms that underlie many of these early
events are being unraveled. Accordingly, genetic mecha-
nisms involving proneural genes Ngn1/2 and the homeo-
domain gene Pax6 have been implicated in the
specification of pyramidal neurons. Similarly, proneural
gene Mash1 and homeodomain genes Dlx 1, 2 that are
specific to basal ganglia are known to direct the specifica-
tion of cortical interneurons [2].
In addition to the intrinsic regulators, numerous extrinsic
signals that influence the cortical progenitors and neurons
have been identified. Among these, chemokines are
known to exert regulatory roles in the developing nervous
system. Stromal derived factor (SDF-1), an alpha chemok-
ine, has been identified in the developing and adult brain.
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that SDF-1 and its receptor CXCR4 are constitutively
expressed in the developing and adult cerebral cortex [3-
5]. Although most chemokines are promiscuous in their
ability to bind to different receptors, SDF-1 is a notable
exception as it is the only known ligand that can bind to
CXCR4 [6], a G-protein coupled receptor.
Interestingly, mutant mice that lack SDF-1, or its receptor
CXCR4, die soon after birth with major developmental
anomalies, including defects in the nervous system [7-9].
While these mutants have reduced cortical thickness the
cerebellum and hippocampus show anomalous develop-
ment. In the present study, using low concentrations of
SDF-1, or AMD3100 in rat primary cultures we demon-
strate that chemokine signaling regulates cell prolifera-
tion, at least in part through a mechanism involving
intercellular communication. Further, SDF-1 enables the
morphological differentiation of cortical glutamatergic
neurons by inducing axon elongation and branching, and
concurrently aids the neurochemical differentiation of
GABAergic neurons. Finally, cortical cultures derived from
CXCR4 mutants also indicate reduced cell proliferation
and neuronal differentiation with fewer GABAergic neu-
rons.
Results
SDF-1 maintains proliferation in primary cortical cultures
Stromal derived factor-1 is expressed in the developing
telencephalon at a time when cell proliferation and differ-
entiation are key events [10,5]. To investigate the role of
SDF-1 signaling in cortical cell proliferation, rat E17 pri-
mary cultures were exposed to a chronic treatment of
chemokine medium (4–6 nM). Subsequent examination
of cultures displayed a significant increase in the number
of proliferating cells, as revealed by Ki67 immunocyto-
chemistry (Fig. 1a; p < 0.01, n = 4 experiments). Con-
versely, treatment with 40 μm of AMD3100, the receptor
antagonist, reduced cell proliferation (p < 0.01, n = 4
experiments). Further, to determine whether chemokine
delays the progenitors from exiting the cell cycle cortical
cultures were pulsed with BrdU for 1 hr and examined
after 5 days of treatment. Analysis of these cultures for
cells that contained BrdU but were negative for Ki67
(BrdU+/Ki67-) showed the fraction of BrdU labeled cells
that exited the cell cycle to become either postmitotic or
quiescent. Accordingly, 91% of the BrdU labeled cells in
control cultures were postmitotic compared to 81% after
SDF-1 treatment (p < 0.01, n = 4 experiments), suggesting
that the chemokine maintains the progenitors in prolifer-
ation. To ensure the presence of applied SDF-1 in culture
medium, chemokine concentration was measured using
ELISA after each application of treatment (Fig. 1b).
Medium collected from control cultures showed the con-
centration of endogenous SDF-1 increasing from approx-
imately 0.15 nM to 0.4 nM in 3 days (n = 2 experiments).
However, treatment with AMD3100 appeared to prevent
the baseline chemokine levels from rising above 0.15 nM,
whereas application of SDF-1 medium caused a cumula-
tive increase to a maximum concentration of 0.8 nM.
Given that chronic exposure to SDF-1 medium increased
the progenitor population, E17 cortical cultures were
pulsed with BrdU to assess the rate of proliferation at dif-
ferent time points of the treatment. Thus, cultures pulsed
with BrdU before the application of treatment corre-
sponding to D1, D3, D5, or 24 hr after D5 were main-
tained for 1 hr and fixed for analysis (see illustration in
Fig. 1c). BrdU labeling of cultures grown in chemokine
medium showed an increased rate of proliferation after 48
hr, which continued to remain high at both days 4 and 5
(Fig. 1d, e; p < 0.001, n = 3 experiments). To further illus-
trate the regulatory role of SDF-1 in cell proliferation, a
cell cluster analysis was performed. In brief, rat E17 intact
cortex was pulsed with BrdU for 1 hr prior to dissociation
and the resulting cell suspension was mixed with non-
BrdU labeled cells. This resulted in a culture containing
clusters of BrdU+ cells in a larger population of unlabeled
cells. Because BrdU is passed on to each daughter cell dur-
ing mitosis the number of progeny in each cluster will
provide an estimate of cell division; only those clusters
that were separated by a minimum distance of 300 μm
were included in the analysis. Initial analysis of cultures
maintained in serum-free defined medium (DM1)
showed BrdU+ clusters of 2 cells that increased to 3 after
24 hr (DM2, prior to commencing treatment). Cultures
grown in control, SDF-1 medium or AMD3100 were ana-
lyzed after 2 or 5 days in treatment (Fig. 1f, g). Clusters in
control cultures contained 3 cells on average, whereas
exposure to SDF-1 medium markedly increased the aver-
age cluster size to 6.5 cells by day 2 (p < 0.01, n = 27 clus-
ters,) and 6.2 cells by day 5 (p < 0.01, n = 18 clusters). We
next investigated whether SDF-1 at the applied concentra-
tion promotes cell survival, or prevents cell death, which
might in part explain its role in proliferation. To assess
cytotoxicity, medium was collected on each day of the
treatment and assayed for released LDH activity (n = 3
experiments). As shown in a representative experiment
(Fig. 2a), the levels of LDH in control and AMD3100
treated cultures increased over time, suggesting a progres-
sive increase in cytotoxicity due to cell death or stress. By
contrast, the degree of toxicity in SDF-1 treated cultures
remained largely unchanged over the course of the exper-
iment. In a separate study we sought to determine if SDF-
1 promotes the survival of cortical cultures (n = 3 experi-
ments). However, MTT assays performed on end point
cultures did not indicate a significant difference in sur-
vival between control and treatment groups (Fig. 2b).Page 2 of 17
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SDF-1 signaling regulates cortical cell proliferationFigure 1
SDF-1 signaling regulates cortical cell proliferation. (a) Graph illustrates a significant increase in proliferation (Ki67+) following 
chronic exposure to SDF-1. (b) ELISA measurements on medium collected from control and treated cortical cultures, DM – 
defined medium. (c) Experimental scheme for BrdU pulsing and cluster analysis; D1–D5 corresponds to 5 consecutive days of 
treatment with control, SDF-1 medium or AMD3100, DM corresponds to cultures in defined medium prior to the application 
of any treatment. Arrows indicate the time points of BrdU applications. (d, e) Graph illustrates the rate of cell proliferation as 
shown by the percent of BrdU+ cells at different days of treatment, while (e) shows representative images of BrdU staining 
(green) against counterstained cells (blue). (f, g) Graph illustrates the average BrdU cluster size at different days of treatment 
and (g) shows representative images of cell clusters; DM1 and DM2 correspond to cultures in defined medium for 24 hr and 48 
hr, respectively. Scale bar: 100 μm.
BMC Developmental Biology 2007, 7:31 http://www.biomedcentral.com/1471-213X/7/31SDF-1 regulates intercellular coupling: a possible 
regulatory mechanism for cortical cell proliferation
It is evident from the above data that SDF-1 through its
downstream signaling exerts a regulatory role in cortical
cell proliferation. Earlier reports have shown that cortical
progenitors express gap junctions and their proteins, con-
nexins [11]. However, more recent studies have high-
lighted that connexin-mediated gap junction channels
and open hemichannels in non-junctional membranes
are two biologically relevant mechanisms by which pro-
genitors can coordinate their responses to the extracellular
environment [12,13]. Thus, we postulated that treatment
with SDF-1 might regulate cell proliferation, at least in
part through hemichannels or through docked gap junc-
tion channels in cortical progenitors. To test this hypo-
thesis a multi-experimental approach was adopted. First,
Cx 43 expression was measured in cortical cultures follow-
ing exposure to SDF-1. Second, cell proliferation was
assayed using Ki67 immunocytochemistry in cultures
grown in SDF-1 medium in concert with carbenoxalone to
block both connexin hemichannels and gap junction
channels [13,14]. Third, intercellular dye-transfer was
assessed in cortical explants using a modified scrape-load
technique. Finally, spontaneous Ca2+ transients were
measured in cortical explants using real time imaging.
To measure Cx 43 protein expression, control and treated
cortical cultures were processed for quantitative immuno-
cytochemistry. Analysis showed a marked increase in Cx
43 protein expression in cultures exposed to chemokine
medium (Fig. 3a; p < 0.01, n = 40 fields). Interestingly,
strong expression of connexin was noted outlining the cell
surfaces as 'plaques' (Fig. 3c green; arrows), typical of gap
junction channels; in controls (Fig. 3b) and AMD3100
treated cultures (data not shown) the pattern of staining
was punctate. To determine whether SDF-1 regulates cell
proliferation through connexin channels, E17 cortical cul-
tures were treated with 10 μM carbenoxalone. Subsequent
processing for Ki67 staining revealed diminished prolifer-
ation in cultures that were exposed to carbenoxalone
alone (Fig. 3d, e, gp < 0.001, n = 35 fields), or together
with SDF-1 medium (Fig. 3d, f, hp < 0.001, n = 22 fields).
This clearly illustrates that SDF-1 mediates cell prolifera-
tion at least in part through connexin hemichannels or
gap junction channels. Consistent with this finding fur-
ther reduction in proliferation was noted in cultures
grown together with AMD3100 and carbenoxalone (Fig.
3d).
To determine whether SDF-1 treatment alters intercellular
dye transfer to reflect gap junction channel coupling a
modified scrape-load technique was used. Briefly, cortical
explants that were whole mounted with ventricular sur-
face on the top were scrape-loaded with a mixture of LY
and rhodamine dextran. The extent of LY transfer was then
quantified into a coupling index (Fig. 3i–m). Remarkably,
explants that were maintained in SDF-1 medium showed
a 2-fold increase in dye-transfer compared to controls
(Fig. 3j–m, p < 0.001, n = 15 explants). Finally, to measure
the spontaneous Ca2+ transients in VZ cells, cortical
explants exposed to either acute (15 min) or chronic (24
hr) SDF-1 treatment were loaded with Oregon Green
BAPTA, a Ca2+ indicator and analyzed using real time
imaging. Images were collected every second and changes
in the average intensity were converted into a 'cell cou-
pling score' [15]. Interestingly, exposure of cortical
explants to either acute or chronic chemokine treatment
significantly increased the frequency of synchronized Ca2+
transients between adjacent VZ cells (acute treatment: Fig.
3n, p < 0.05, n = 19 pairs of cells; chronic treatment: Fig.
3o, p < 0.01, n = 33 pairs of cells). To confirm that the cou-
pling was indeed in the cortical VZ, explants were subse-
quently fixed and processed for Ki67
immunocytochemistry (data not shown). Taken together,
these results illustrate that SDF-1 signaling regulates inter-
cellular coupling and Cx 43 protein expression in cortical
Cell death and cell survival assaysFigur  2
Cell death and cell survival assays. (a) Graph illustrates a rep-
resentative LDH assay for measurement of cytotoxicity in 
medium collected from control, SDF-1 and AMD3100 
treated cortical cultures; samples were assayed in triplicates 
for each time point. (b) Graph illustrates MTT assay for cell 
survival in control, SDF-1 and AMD3100 treated cortical cul-
tures.Page 4 of 17
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SDF-1 regulates connexin 43 expression and intercellular couplingFigure 3
SDF-1 regulates connexin 43 expression and intercellular coupling. (a-c) Graph illustrates changes in Cx 43 immunoreactivity 
following SDF-1 and AMD3100 treatments in primary cortical cultures. (b, c) Representative images of control (b) and SDF-1 
treated (c) cultures stained for Cx 43 (green) and DAPI counter stain (blue); arrows in (c) indicate 'plaque-like' labeling of Cx 
43 immunoreactivity around cell surfaces, in contrast to the punctate staining visible in control culture. (d-h) Graph shows the 
percent of proliferative population (Ki67+ cells) in various treatments applied to cortical cultures. (e-h) Examples of Ki67+ 
cells (green) counterstained with DAPI (blue) in control (e), SDF-1 (f), carbenoxalone (g) SDF-1 + carbenoxalone (h) treated 
cultures. (i-m) Graph shows the extent of LY dye transfer in E17 whole mounted cortical explants that were maintained in var-
ious treatment conditions. (j-m) Examples of low and high magnification images illustrating dye transfer in control (j, k) and 
SDF-1 treatment (l, m), respectively; * on images indicate the scrape line. (n-p) Graphs indicate synchronized calcium transients 
measured in E17 whole mounted cortical explants that were in acute (n) and chronic (o) treatments. Synchronized transients 
were measured between adjacent cells in the cortical VZ as shown in a representative image (p). Scale bar: j, l, 250 μm; b, c, e-
h, k, m, 100 μm.
BMC Developmental Biology 2007, 7:31 http://www.biomedcentral.com/1471-213X/7/31progenitors. Although, it is very likely that the coupled
progenitors express Cx 43 the contribution of other con-
nexins cannot be ruled out.
SDF-1 signaling regulates the differentiation of cortical 
neurons
To investigate the role of SDF-1 signaling in regulating
neuronal differentiation, rat E17 cortical cultures were
immunolabeled for Neu-N, a neuron specific marker.
Analysis did not indicate a significant difference in the
output of neurons between control and treatment groups
(Fig. 4a), suggesting that the chemokine does not affect
the differentiation of glutamatergic neurons, which con-
stitute 80–85% of all cortical neurons as has been shown
in both in vivo and in vitro studies [16-18]. Next, to exam-
ine whether SDF-1 signaling regulates the differentiation
of cortical GABAergic neurons cultures were processed for
GABA immunocytochemistry. Interestingly, a 2-fold
increase in GABA+ neurons was noted in cultures grown
in SDF-1 medium compared to controls (Fig. 4b–d, p <
0.001, n = 47 fields). Recent studies have implicated a role
for Shh signaling in the differentiation of cortical GABAer-
gic neurons [19]. As SDF-1 has been shown to modulate
Shh signaling in the developing cerebellum [20] we rea-
soned that a similar mechanism might regulate the differ-
entiation of cortical GABAergic neurons. Thus, cortical
cultures were exposed to cyclopamine, a Shh antagonist
[19], alone or in the presence of SDF-1 medium.
Although, application of cyclopamine to control cultures
did not show a marked difference in the output of neu-
rons as indicated by Neu-N staining, an increase was
noted in the expression of GABA+ neurons (Fig. 4e, p <
0.001, n = 23 fields). Further, cultures grown in SDF-1
medium together with cyclopamine also showed elevated
GABA expression, similar to the response noted with
either of the treatments alone (Fig. 4e, p < 0.01, n = 33
fields).
We next asked whether the increase in GABA expression
would be reflected in the early subtypes of cortical
interneurons. Thus, E17 cortical cultures were examined
for calretinin, an early interneuronal subtype, following
treatment with chemokine or antagonist. Remarkably,
application of chemokine significantly increased the cal-
retinin+ neurons (Fig. 4f, p < 0.05, n = 20 fields), whereas
the antagonist reduced the expression by 75%.
SDF-1 signaling regulates axon growth and branching in 
cortical neurons
Stromal derived factor-1 signaling has been shown to reg-
ulate axon outgrowth in the developing cerebellum and
hippocampus [21,22]. Thus, to examine whether the
chemokine exerts a similar regulatory mechanism in the
developing cortex, E17 cultures were transfected with GFP
to randomly label cells. A transfection efficiency of 20–25
GFP+ cells/coverslip was chosen for the morphological
analysis of neurite outgrowth. Following transfection, cor-
tical cultures were maintained in control, SDF-1 medium
or AMD3100 as described previously. Although, the long-
est neurite was defined as an axon [22], immunocyto-
chemistry was performed to label neurofilaments that are
specific to axons (data not shown). Quantitative analysis
confirmed that GFP+ neurons grown in SDF-1 medium
showed a greater degree of morphological differentiation
with elongated axons compared to those grown in control
conditions (Fig. 5a–f, p < 0.05, n = 45 cells). Further, SDF-
1 increased the frequency of axon branching, however the
treatment did not alter the number of branches, at least at
the low concentrations of chemokine used (Fig. 5g, p <
0.001, chi-square test, n = 45). To characterize the pheno-
type of GFP+ neurons, control and treated cultures were
labeled for GABA immunoreactivity. Interestingly, 95% of
GFP+ neurons in both groups were GABA negative, thus
confirming their glutamatergic origin (Fig. 6a, b). Further,
cortical glutamatergic pyramidal neurons are known to
have extended axons; this also alludes to the phenotype of
GFP+ neurons in treated cultures as glutamatergic neu-
rons (Fig. 6c).
Proliferation and neuronal differentiation are altered in 
CXCR4-/- mutant cortical cultures
In agreement with the data from antagonist treatment,
examination of E15 cortical cultures derived from CXCR4-
/- mutant mice showed diminished proliferation as evi-
denced by Ki67 immunocytochemistry (Fig. 7a, p < 0.001,
n = 47 fields from 9 mutants). Further, estimation of
mitotic profiles confirmed reduced mitotic activity in
CXCR4-/- cultures compared to wild type controls (data
not shown). Screening of cultures stained for propidium
iodide or trypan blue indicated a marked increase in cell
death in mutant cultures compared to wild type (Fig. 7b,
p < 0.001, n = 47 fields from 9 mutants). To assess neuro-
nal differentiation, cultures were processed for Neu-N and
GABA immunocytochemistry. Analysis of mutant cultures
revealed diminished output in both the total neurons
(Fig. 7c, p < 0.001, n = 68 fields) and GABAergic popula-
tion compared to wild type controls (Fig. 7d, p < 0.01, n =
45 fields). Previous studies have indicated reduced corti-
cal thickness in CXCR4-/- mutants with no gross defect.
Consistent with the earlier findings, staining of E15
mutant brain sections (n = 3 mutants) for Ki67 indicated
a mild anomaly in the proliferative population [see Addi-
tional file 1]. Line-scan analysis of immunolabeled sec-
tions (n = 5 representative sections/brain) showed
reduced pixel intensity (approximately 20%) in mutant
cortex compared to wild type [see Additional file 1].
Although, examination of wild type and mutant brain sec-
tions did not show a notable difference in neuronal stain-
ing [see Additional file 1], labeling for GABA displayed an
altered pattern of immunoreactivity. Typically, GABAergicPage 6 of 17
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SDF-1 regulates the differentiation of cortical neuronsFigure 4
SDF-1 regulates the differentiation of cortical neurons. (a) Graph shows the percent of postmitotic neurons (Neu-N + cells) in 
control and treated cortical cultures. (b-d) Graph illustrates the percent of GABA+ neurons in various treatments applied to 
cortical cultures (b). Examples of images from control (c) and SDF-1 treated (d) cultures stained for GABA immunoreactivity; 
arrows indicate labeled cells. (e) Treatment with cyclopamine (Shh antagonist) alone or together with SDF-1 increased the 
GABA expression, suggesting a sonic independent mechanism. (f) Graph shows the percent of calretinin immunoreactivity in 
control and treated cultures. Scale bar: 100 μm.
BMC Developmental Biology 2007, 7:31 http://www.biomedcentral.com/1471-213X/7/31neurons that originate in the ventral telencephalon
migrate tangentially through the subventricular zone,
intermediate zone and marginal zone [23,24]. However,
in the mutants the marginal zone contained distinctly
fewer GABA+ neurons while the intermediate zone
appeared to have increased immunoreactivity compared
to those in wild type tissue [see Additional file 1]. Similar
pattern of staining was observed with calbindin, also a
marker of migrating cortical GABAergic neurons (data not
shown).
SDF-1 promotes axon elongation and branching in cortical neuronsFigure 5
SDF-1 promotes axon elongation and branching in cortical neurons. (a-f) Representative reconstructions of GFP labeled neu-
rons in SDF-1 treated (a-c) and control (d, e) cultures; note the elongated and branched axons in SDF-1 treatment compared 
to shorter axons in controls (arrows). (f) Graph illustrates the average length of GFP+ axons in control and treated cultures. 
(g) Stacked graph shows the frequency of branching in control and treated cultures. Scale bar: 90 μm. ****: Significance at p < 
0.0001 (chi-square test).Page 8 of 17
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To identify the differentially expressed transcripts follow-
ing chemokine treatment, total RNA was extracted from
rat E17 cortical cultures grown in control, SDF-1 medium
or AMD3100; three biological replicates were used for
each experimental condition. The synthesized cRNA was
labeled and hybridized to Affymetrix rat genome RG-
230v2 microarrays according to the manufactures guide-
lines. Following background correction and normaliza-
tion, the intensities of the biological replicates were
averaged to obtain the mean expression value for each
transcript in all experimental conditions. Thus, every data
point in figures 8a–d represents the average of three inde-
pendent hybridizations (biological replicates). Figure 8a
illustrates the change in the mean expression level of all
hybridized transcripts (31,042 probes). The dataset was
then filtered using a threshold for expression level and
fold change to generate a list of 584 transcripts. Of these,
12% of the transcripts showed an upregulated expression
greater than 2-fold following treatment with SDF-1, while
37% displayed an intermediate expression that was less
than 2-fold (transcripts between fold lines x2 and x1; Fig.
8b). By contrast, 72% of the probes showed a near 2-fold
down regulation in response to AMD3100 treatment
(transcripts between fold lines/2 and x1; Fig. 8c). The fil-
tered data was further processed using K-means with Pear-
son correlation and pre-specified number of clusters to
group transcripts into sets of clusters. This analysis yielded
a cluster of 142 transcripts that showed an upregulated
response to SDF-1 and conversely down regulated in the
presence of AMD3100 (Fig. 8d). Among these, Cx 43 and
secreted frizzled related protein 1 (Sfrp1) were of direct
relevance for the regulatory functions of SDF-1 in cell pro-
liferation and axon growth, respectively. These two tran-
scripts showed a marked upregulation of 1.9-fold and 2.4-
fold in response to SDF-1 treatment, respectively. Subse-
quent validation with qRT-PCR confirmed that Cx 43 and
Sfrp1 were indeed upregulated by SDF-1, although the
Characterization of GFP labeled neurons in cortical culturesFigure 6
Characterization of GFP labeled neurons in cortical cultures. (a, b) Representative images of GFP transfected control (a) and 
SDF-1 treated (b) cultures labeled for GABA immunoreactivity (red staining). (c) Image of a GFP+ neuron with an extended 
axon in SDF-1 treated culture. Scale bar: a, b, 30 μm; c, 150 μm.Page 9 of 17
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microarray analysis (Fig. 8e).
Discussion
SDF-1 signaling maintains cortical progenitors in 
proliferation by facilitating intercellular coupling
Treatment of rat E17 cortical cultures with SDF-1 medium
showed a marked increase in proliferation as evidenced by
Ki67 immunocytochemistry and BrdU labeling tech-
niques. The increase in the number of BrdU+ cells in
defined medium suggests a cell cycle length of 20–24 hr
consistent with earlier reports [25]. Our experiments indi-
cate that the progenitors are likely to have divided asym-
metrically [26] to yield 3- cell clusters in defined medium,
which then continued to generate clusters of 6.5 cells after
48 hr in SDF-1 treatment. In support of this view, quanti-
tative estimation of cells that were BrdU+/Ki67- suggests
that SDF-1 impedes the progenitors from exiting the cell
cycle. By contrast, the proportion of dividing cells in con-
trol cultures was less, as many would have exited the cell
cycle to become either postmitotic or quiescent. Taken
together, it is evident that SDF-1, at concentrations less
than 10 nM, maintains the cortical progenitors in prolif-
eration and possibly enables their survival by reducing
cytotoxicity. However, it is less likely for the treatment to
have shortened the cell cycle time, or switched the mode
Proliferation and differentiation are reduced in E15 CXCR4-/- cortical culturesFigure 7
Proliferation and differentiation are reduced in E15 CXCR4-/- cortical cultures. (a, b) Graphs show diminished proliferation as 
evidenced by Ki67 immunolabeling (a) and increased cell death quantified by propidium iodide or trypan blue staining (b) in 
mutant cultures compared to wild type controls. (c, d) Staining of cultures for Neu-N also showed fewer postmitotic neurons 
(c) and GABAergic neurons (d) in mutant cultures compared to wild type controls.Page 10 of 17
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SDF-1 signaling activates downstream genesFigure 8
SDF-1 signaling activates downstream genes. (a-d) Illustrates data from Affymetrix rat genome RG-230v2 microarrays analysis; 
every data point represents the average of 3 independent hybridizations (biological replicates) per experimental condition. (a) 
Illustrates the change in the mean expression level of all hybridized transcripts between control and SDF – treatment. (b, c) 
Illustrates transcripts that showed a near 2-fold (37%) or greater than 2-fold (12%) up regulation in SDF-1 treatment (b), and a 
near 2-fold (72%) down regulation in AMD3100 treatment (c) compared to controls. (d) Cluster analysis shows genes of bio-
logical significance being grouped together (e) qRT-PCR analysis to validate the gene expression of Cx 43 and Sfrp1.
BMC Developmental Biology 2007, 7:31 http://www.biomedcentral.com/1471-213X/7/31of cell division from asymmetric to symmetric division. It
is pertinent to note that in the proliferation of cerebellar
granule cells the mitogenic potency of SDF-1 is only
apparent in concert with Shh, a potent mitogen expressed
by Purkinje neurons [20]. Interestingly, a recent study has
highlighted that SDF-1 induces the proliferation of corti-
cal neurospheres that were expanded in basic fibroblast
growth factor (bFGF), a known mitogen [27]. Remarka-
bly, the mitogenic effect of SDF-1 noted in our prepara-
tions has close parallels to the activity of bFGF in rat
cortical cultures [28]. Accordingly, the growth factor
maintains the progenitors in cycle by increasing the
number of cell divisions, stimulates the quiescent cells
into proliferation and enables their survival without
shortening the length of cell cycle. Although, a direct link
between SDF-1 and bFGF is yet to be shown, it is more
likely that both factors share common downstream sign-
aling mechanisms that facilitate the proliferation of corti-
cal progenitors. Notably, ERK1/2 and PI-3 kinase
pathways have been implicated in the SDF-1 induced pro-
liferation of bFGF- expanded neurospheres [27]. In agree-
ment with the data from antagonist experiments in rat
cultures, examination of CXCR4-/- cultures showed
diminished mitotic activity and increased cell death. Fur-
ther, staining of mutant brain sections for Ki67 immuno-
reactivity revealed a minor anomaly in cell proliferation
consistent with the earlier finding of reduced cortical
thickness [29].
Earlier studies have demonstrated that cortical progeni-
tors are coupled by a network of gap junction channels
that regulate the entry of dividing cells into S-phase
[30,11,31]. However, it is now evident that undocked
connexin hemichannels distributed in the progenitors
during late G1 or S-phase propagate spontaneous Ca2+
transients that may modulate proliferation [13]. In our
experiments treatment with SDF-1 significantly increased
the cortical progenitor population (Ki67+ cells), which
declined sharply when exposed to carbenoxalone, a
blocker of both connexin hemichannels and gap junction
channels. Further, treatment of cortical cultures with
chemokine medium increased Cx 43 immunoreactivity
with a pattern of staining that was robust and predomi-
nantly localized to the cell surface. Thus, to distinguish
whether chemokine treatment influences the undocked
connexin hemichannels or gap junction channels, LY dye
transfer experiments were performed in whole mounted
cortical explants. Interestingly, the scrape-load technique
clearly illustrated that in the presence of SDF-1 medium
the degree of dye transfer was significantly more on both
sides of the scrape line compared to control explants.
Although, a few cells at the ventricular surface were filled
with LY, possibly through open hemichannels, they were
located away from the scrape line in both control and
SDF-1 treated explants. Open hemichannels are known to
be prevalent in lower Ca2+ conditions [14], thus few
undocked channels may have remained open in our prep-
arations as they were maintained in regular Ca2+ contain-
ing medium. In this context, our calcium imaging
experiments corroborate the LY dye transfer data. As Ca2+
transients were recorded from cells that were positioned
within a depth of three layers from the VZ surface, it is very
likely these cells were in late G2, M or early G1 phase of the
cell cycle. Based on the premise that connexin hemichan-
nels are distributed on the membranes of progenitors in
late G1 or S-phase [13], the spontaneous Ca2+ transients
recorded in our experiments are likely to have propagated
through gap junction channels.
SDF-1 mediated differentiation of cortical neurons
Our experiments showed that SDF-1 treatment signifi-
cantly up regulates the differentiation of GABAergic neu-
rons, including the calretinin subtype. Although
chemokine treatment has been shown to promote the sur-
vival of neurons in other systems [32], we believe that
alone cannot increase the differentiation of GABAergic
neurons. A growing body of evidence now suggests that
cortical progenitors do have the competency to generate
GABAergic neurons in vitro [16,19,33].
Interestingly, while the work of Gulacsi and Lillien
showed that the balance between the inductive and
repressive signals of Shh and BMP, respectively, deter-
mines the expression of GABA+ neurons, Nery and col-
leagues have illustrated that cortical progenitors are
competent to express Dlx 2 in vitro. In light of these earlier
reports, it is plausible for the chemokine signaling to have
induced the generation of cortical GABAergic neurons in
vitro. However, staining of control and treated cultures for
BrdU and GABA immunocytochemistry did not yield a
quantifiable co-labeling to suggest that GABAergic neu-
rons were generated in vitro (data not shown). Thus, it is
conceivable that SDF-1 induced the expression of GABA
in postmitotic neurons that were yet to assume a neuro-
transmitter identity. Alternatively, a subset of cortical
glutamatergic neurons may have transiently expressed
GABA in response to chemokine treatment. Although, our
experiments illustrated an increase in GABA+ neurons in
response to SDF-1, it is not known whether these cells
function as inhibitory interneurons, or would continue to
express GABA in the absence of chemokine signaling. Fur-
ther, the effects of SDF-1 and antagonist treatment were
notably evident in the cortical calretinin population. Cal-
retinin, a marker of preplate cells during early develop-
ment is later expressed in a subset of GABAergic neurons.
Because our rat cultures were derived from embryos of
mid corticogenesis stage, it is less likely for the chemokine
treatment to have induced the differentiation of preplate
neurons. Moreover, the majority of calretinin+ neurons in
our cultures appeared bipolar in shape, suggesting aPage 12 of 17
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exhibit multipolar morphology in vitro [34]. Interestingly,
cortical cultures derived from CXCR4-/- mice also showed
diminished neuronal differentiation and importantly
fewer GABAergic neurons. Consistent with these culture
experiments, examination of E15 mutant brain sections
showed distinctly fewer GABA+ neurons in the marginal
zone compared to wild type tissue. It is possible that loss
of chemokine signaling may have dispersed or misdi-
rected the movement of a subset of neurons from the mar-
ginal zone towards the intermediate zone, as an increase
in GABA immunoreactivity was noted in the latter region.
In this context, it is pertinent to note that secreted SDF-1
in the meninges enhances the dispersion of a subset of
Cajal-Retzius cells derived from cortical hem and that loss
of chemokine activity causes disorganization of these cells
[35,36]. Sonic hedgehog signaling has been implicated in
the generation of cortical GABAergic neurons [19]. How-
ever, in our experiments blocking of Shh signaling with
cyclopamine increased the output of GABA+ neurons
alone or in concert with SDF-1. This suggests, unlike in
cerebellum [20], SDF-1 signaling does not interact syner-
gistically with Shh, at least for the differentiation of
GABAergic neurons.
A noteworthy finding was the elongation of axons of cor-
tical projection neurons in cultures exposed to chemokine
medium. In addition, neurons that showed axon branch-
ing with one or more collaterals were prevalent in cultures
grown in SDF-1 medium. Similar findings have been
reported in cultured cerebellar granule neurons [21] and
hippocampal neurons [22]. Accordingly, both groups of
neurons responded differently to SDF-1 treatment
depending largely on the applied dosage; lower concen-
trations of chemokine induced axon elongation in cere-
bellar granule neurons with apparently no change in the
number of branches, while higher concentrations abol-
ished the effects. It is relevant to note that the concentra-
tion of chemokine used in our experiments was much
lower and closer to the physiological limits than those
used in earlier studies. What might be the significance of
SDF-1 mediated regulation of cortical axons? A recent
study has highlighted that SDF-1 through its G-protein
coupled receptor modulates the repellent activities of Slit-
2 in cultured retinal ganglion cell axons [32]. Given that
Slit-1, a repellent of cortical axons [37], closely follows the
endogenous expression of SDF-1 in the developing cortex
raises the possibility that the chemokine might modulate
the repressive signals and provide a permissive environ-
ment for the cortical afferents.
Down stream gene activation of SDF-1 signaling
Using gene chip analysis together with qRT-PCR, we have
explored the activation of downstream genes following
chemokine treatment in cortical cultures. Among the
genes of interest that were identified, Cx 43 showed a 2-
fold rise following SDF-1 treatment thereby validating the
findings of increased protein expression and intercellular
coupling. Another gene of relevance to the regulatory
function of SDF-1 is Sfrp1, which showed an upregulated
expression greater than 2-fold. Interestingly, Sfrp1,
expressed in the developing cortical VZ [38], has been
shown to promote neurite outgrowth in retinal neurons in
vitro [39]. Thus, it is entirely plausible that elevated Sfrp1
may have contributed to the elongation of axons as visu-
alized in our cortical cultures. In addition, the upregula-
tion of MAP1b, Ncam1 and MAP kinases 1 and 9 that are
components of many downstream signaling pathways
may have directly or indirectly contributed to the regula-
tory functions of SDF-1 in cortical cultures.
Conclusion
Using cellular, molecular and functional assays the
present study demonstrates that SDF-1 signaling exerts
multiple regulatory roles on distinct cortical cell popula-
tions in vitro. Our results demonstrate that exogenous
SDF-1, at low concentrations, can exert a mitogenic effect
by retaining the cortical progenitors in proliferation pos-
sibly through enhanced intercellular communication.
Concurrent to its role in proliferation, chemokine signal-
ing regulates the morphological differentiation of cortical
glutamatergic neurons and enables the neurochemical
differentiation of GABAergic neurons. The existing
CXCR4-/- and SDF-1-/- mutants do not provide a clear
phenotype in the cortex, possibly due to compensatory
mechanisms. In the absence of adequate genetic
approaches to elucidate the in vivo significance of SDF-1
and CXCR4, the emerging in vitro and ex vivo studies indi-
cate that the chemokine signaling plays an important reg-
ulatory role in the developing cerebral cortex and the
nervous system at large.
Methods
Preparation of SDF-1 conditioned medium
Confluent HEK293 cells, cultured in the presence of
DMEM: F12 (Sigma), 10% fetal bovine serum, 100 μM L-
glutamine, 5 U/ml penicillin and 5 mg/ml streptomycin
in a humidified 5% CO2 incubator at 37°C, were trans-
fected with rat SDF-1α cDNA (GenBank AF209976 ampli-
fied from rat cDNA library) that had been sub cloned into
a pcDNA3 vector (mouse and rat SDF-1α amino acid
sequences share 97% identity). For controls, mock trans-
fections were prepared using DNA-free transfection solu-
tion. Supernatant was collected after 48 hr from SDF-1
transfected (SDF-1 medium) and untransfected cultures
(control medium) and stored at -20°C for future applica-
tion.Page 13 of 17
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The concentration of rat SDF-1 was measured by enzyme
linked immunosorbent assay with modifications to a
commercially available kit (Quantikine human SDF-1α;
R&D Systems). Briefly, 50–100 μl of culture medium or
standards of known concentration of SDF-1 were added to
each well of 96-well microplates, pre-coated with mouse
monoclonal antibody to SDF-1α. The plates were incu-
bated at room temperature for 2–3 hr, washed (×4) with
wash buffer and treated with 200 μl/well of horseradish
peroxidase-conjugated polyclonal antibody to SDF-1α.
The plates were further incubated for 2–3 hr, washed (×4)
and treated with 200 μl/well of freshly prepared tetrame-
thylbenzidine in hydrogen peroxide and kept in the dark
for 45 min. Reaction was then arrested with 50 μl/well of
2 M sulphuric acid, after which the absorbance was meas-
ured at 450 nm using a micro plate reader.
Primary neural cell cultures
Cortices (excluding hippocampus) were isolated from rat
E17 brains and dissociated as described previously [40].
Cells, plated at a density of 1.5 × 105 on poly-L-Lysine/
laminin (10 μg/ml) coated glass coverslips, were main-
tained for 24 hr in 10% serum containing medium and
thereafter transferred to serum-free defined medium sup-
plemented with 1 × N2 (Invitrogen). To test the effect of
chemokine, serum-free cultures were treated with chem-
okine medium (4–6 nM SDF-1) or grown in control
medium (mock transfected HEK cell medium). Likewise,
to block receptor activity, serum-free cultures were grown
in 40 μM of AMD3100 (NIH), dissolved in DMSO (final
concentration 1:1000). To verify the cytotoxicity of
DMSO, pilot experiments were performed with appropri-
ate vehicle controls. To block gap junction coupling, cul-
tures were exposed to 1 μM carbenoxalone, or to inhibit
sonic hedgehog signaling 5 μM cyclopamine was used.
Once in serum-free defined medium, cultures were treated
with control, chemokine medium or AMD3100 every 24
hr for 5 consecutive days and fixed for immunocytochem-
istry.
To assay cell proliferation on different days of the experi-
ment, cultures were pulsed with 30 μM BrdU for 1 hr
before the application of treatment appropriate for the
day. To visualize and quantify neuronal processes, pri-
mary cultures grown in either control or treatment
medium were transfected with GFP construct using Lipo-
fectamine 2000.
CXCR4 -/- mice
B6.129X-Cxcr4tm1Qma/J mice were obtained from Jack-
son Laboratory (Maine, USA). Genotyping of tissue was
carried out as described previously [41]. Primary neural
cultures were prepared from E15 wild type and mutant
cortex as described above. Once in serum free conditions,
cultures were further maintained for 5 days in defined
medium supplemented with 1 × N2 and fixed for immu-
nocytochemistry. To examine the pattern of immunos-
taining of Ki67, MAP2, GABA and calbindin in brain
sections, E15 wild type and mutant brains were fixed in
4% paraformaldehyde/0.1 M phosphate buffer and sec-
tioned using a cryostat. Coronal sections were processed
for immunocytochemistry as described below.
LDH and MTT assay
Medium collected from control and treated cultures every
24 hr was assayed for LDH activity to obtain a measure of
cytotoxicity. The assay is based on the conversion of tetra-
zolium salt into a red formazan product by LDH released
from lysed cells. The intensity of color, proportional to the
degree of cytotoxicity, was quantified by measuring
absorbance at 492 nm (n = 3 experiments). To assay cell
survival, control and treated cultures were incubated with
MTT for 2 hr at the end of the experiment (end point cul-
tures). Medium containing purple formazan crystals,
formed by active mitochondrial enzymes, was dissolved
in DMSO and the intensity measured at 560 nm (n = 3
experiments).
Preparation of cortical explants
Cortical explants were prepared from rat E17 brains.
Briefly, embryonic cortices dissected free from the adja-
cent hippocampus and underlying eminence were flat-
mounted onto 0.45 μm nitrocellulose filters with VZ sur-
face on the top. The explants were then maintained in
control or treatment medium for 1–2 days.
Immunocytochemistry
Primary cells were fixed in 4% paraformaldehyde/0.1 M
phosphate buffer (pH 7.4) and processed for immunocy-
tochemistry. Cells were incubated overnight with primary
antibodies for BrdU (mouse monoclonal, 1: 300, Progen),
GABA (rabbit polyclonal, 1:750, Sigma), calbindin (rab-
bit polyclonal, 1:750, Swant), calretinin (rabbit polyclo-
nal, 1:750, Swant), NeuN (mouse monoclonal, 1: 400,
Chemicon), MAP2 (mouse monoclonal, 1:500, Sigma),
Ki67 (rabbit polyclonal, 1:750, Chemicon) or connexin
43 (1: 100, Zymed). After washing, cells were incubated
with FITC or rhodamine-conjugated secondary antibodies
(mouse or rabbit, 1:500, Molecular Probes,) at room tem-
perature for 2 hr. Labeled cells were counterstained with
DAPI and examined with a Nikon EC600 fluorescent
microscope equipped with a cooled CCD system. Sequen-
tial images were subsequently reconstructed using Meta-
morph imaging software.
Image analysis
To measure the relative abundance of Cx 43 immunoreac-
tivity a modified method was adopted [42]. All images
were analyzed using Metamorph imaging software.Page 14 of 17
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treated samples were initially processed for background
subtraction followed by removal of single pixels using
median filter. Based on the pixel intensities, which ranged
from 0–255, Cx 43 signal was distinguished from the
background by empirically determining an intensity value
of 80. Images were then thresholded and the fluorescent
signal was measured using the automated function of the
software. Total cell count per image was obtained by
counting DAPI stained nuclei. Because of the varying
degree of protein expression, the fluorescent signal is pre-
sented as 'average Cx 43 expression per cell'.
Calcium imaging
E17 cortical explants that were maintained in either con-
trol or treatment medium for 1–2 days were loaded with
Oregon Green BAPTA for 20 min (10 μM/ml; Molecular
probes) and transferred to a temperature controlled glass
chamber (35–37°C) for image acquisition. Images were
collected every second for at least 3–5 min and subse-
quently analyzed using Metamorph imaging software.
Change in fluorescent intensity was converted into a cou-
pling score. A coupling event was defined as a 10% or
greater change in fluorescent intensity between pairs of
neighboring cells [15].
Dye transfer in cortical explants: scrape load method
To test for dye coupling, rat E17 cortical explants that were
maintained in either control or treatment medium for 1–
2 days were scrape loaded [43]. Briefly, a sharp incision
was made across the explants and loaded with a mixture
of 1% Lucifer yellow/rhodamine dextran for 20 min.
Explants were then fixed and images were acquired for
analysis. To ensure that the explants were mounted with
the VZ surface on the top, they were processed for Ki67
immunocytochemistry to label proliferative cells. The
degree of dye transfer was converted into a coupling index
defined by the ratio between LY labeled area and the
length of corresponding cortical explant.
DNA microarrays
Briefly, rat E17 control and treated cultures (litter of
embryos/biological replicate) were homogenized in tri-
zol. The RNA precipitated from the aqueous phase by the
addition of isopropanol was washed, air dried and quan-
tified. Microarrays were used as described in the Affyme-
trix gene chip technical manual. Briefly, 15 μg of total
RNA was converted to cDNA followed by in vitro tran-
scription for linear amplification of transcripts and incor-
poration of biotinylated CTP and UTP. The cRNA
products were fragmented to 200 nucleotides or less,
labeled and hybridized for 16 hr at 45°C to Affymetrix rat
genome RG-230v2 microarrays. The arrays were washed at
low and high stringency before staining with streptavidin-
phycoerythrin. Fluorescence was amplified using bioti-
nylated anti-streptavidin followed by incubation with
streptavidin-phycoerythrin stain. Technical quality con-
trol was performed with dChip (V2005) using the default
settings. Background correction and quantile normaliza-
tion were performed using RMA Express [44]. Normalized
data was filtered first on expression intensity and then by
fold change in expression using GeneSpring software (Agi-
lent Technology). Genes of interest were subsequently val-
idated with qRT-PCR.
Quantitative RT-PCR
Using real-time quantitative PCR method, the relative
quantity of transcripts was measured in control and
treated samples. All genes of interest were first normalized
with GAPDH and β-actin, the house keeping genes. The
relative abundance of transcripts in treated samples (SDF-
1 and AMD3100) was then expressed as fold change com-
pared to those measured in controls. To ensure there was
no DNA contamination, RNA samples were first treated
with DNase. cDNA was then generated by reverse tran-
scription: briefly, samples were incubated with 25 ng/μl
random primers and 0.77 mM dNTPs for 5 min at 65°C.
After 1 min on ice, samples were centrifuged briefly and
incubated with 50 mM Tris-HCl, 75 mM KCl, 3 mM
MgCl2, 5 mM DTT, 2 units RNase inhibitor, and 10 units
reverse transcriptase for 5 min at 25°C. For reverse tran-
scription the mixture was left at 50°C for 45 min and the
reaction inactivated by heating to 70°C for 15 min. The
prepared cDNA was stored at -20°C. Taqman qRT-PCR
[45] was performed in 96-well plates; cDNA (5 μl per
well) was added to 10 μl 2× master mix to yield 5 mM
MgCl2 containing uracil-N-glycosylase (UNG), 0.8 μM of
relevant primer and 0.4 μM of relevant probe. PCR reac-
tions and analysis were carried out using an ABI Prism
7700 Sequence Detector. Briefly, 50°C for 2 min, 95°C
for 10 min followed by 35–40 cycles of 92°C for 15 sec
and 60°C for 60 sec. Primer and probes were designed
and chosen using the Roche Applied Science Probe Finder
software v2.10.
Statistical analysis
To determine the level of significance between control
and various treatments, analysis of variance (ANOVA) was
used with Bonferroni's posttest correction. To compare
the significance between two parametric variables, Stu-
dent's unpaired t-test was performed while for the analysis
of categorical variables (branched or unbranched axons)
chi-square analysis was used. Error bar in graphs represent
standard error of the mean and *, **, ***, indicates sig-
nificance at p < 0.05, p < 0.01 and p < 0.001, respectively.
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